INVOKANA
- Product NDC
- 50090-5029
- 11-digit product format
- 500905029
- Labeler code
- 50090
- Product ID
- 50090-5029_4a627123-1563-4586-9cde-6588413cbb60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- canagliflozin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA204042
- Marketing category
- NDA
- Marketing start
- 2013-03-29
- Substance
- CANAGLIFLOZIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- INVOKANA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CANAGLIFLOZIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0SAC974Z85 |
| Rxcui | 1373471, 1373473 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5029-0 | INVOKANA | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5029 | INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 1 package rows | 20231025_4e946ba3-02c4-4a10-9d5e-f2d87b534dc3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5029-0 | 50090502900 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0) | 2020-04-28 | 0000-00-00 | No | No | Current |